60 Degrees Pharma Inc-28 (SXTPW) Institutional Buying & Selling Tracker (Q2 2026)

SXTPW ranks #11882 out of 37507 tracked stocks by institutional interest, inside the more closely watched half of our coverage.

5 institutions disclose a position in SXTPW, but none treat it as a major bet — even Walleye Capital LLC, its most concentrated holder, allocates just 0.0% of its own portfolio to it.

Walleye Capital LLC has trimmed its SXTPW position for two straight quarters, cutting it by $6.6K while still holding $6.1K.

SXTPW reported a net loss of $8.1M over the trailing twelve months.

• Not yet profitable — net loss of $8.1M over the trailing twelve months
• Revenue grew 76.2% year over year
• Net income declined year over year, from -$7.8M to -$8.1M
• Operating cash flow was negative, using $6.8M in cash
• Current ratio of 2.66x — enough short-term assets to cover short-term liabilities
• Liabilities run 0.57x equity — within a conventional range